These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8007761)

  • 21. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
    Valchar M; Hanbauer I
    J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]GBR-12935 binding to human cerebral cortex is not to dopamine uptake sites.
    Allard P; Danielsson M; Papworth K; Marcusson JO
    J Neurochem; 1994 Jan; 62(1):338-41. PubMed ID: 8263533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GBR 12909 fails to antagonize cocaine-induced elevation of dopamine in striatal slices.
    Gifford AN; Bergmann JS; Johnson KM
    Drug Alcohol Depend; 1993 Mar; 32(1):65-71. PubMed ID: 8486086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
    Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
    Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of [3H]mazindol binding sites in rat striatum by dopaminergic agents.
    Ikawa K; Watanabe A; Kaneno S; Toru M
    Eur J Pharmacol; 1993 Dec; 250(2):261-6. PubMed ID: 7906653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
    Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]GBR-12935 binding to dopamine uptake sites in the human brain.
    Marcusson J; Eriksson K
    Brain Res; 1988 Aug; 457(1):122-9. PubMed ID: 3167558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
    Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
    Billaud G; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]GBR-12935 binding to cytochrome P450 in the human brain.
    Allard P; Marcusson JO; Ross SB
    J Neurochem; 1994 Jan; 62(1):342-8. PubMed ID: 8263534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease.
    Janowsky A; Vocci F; Berger P; Angel I; Zelnik N; Kleinman JE; Skolnick P; Paul SM
    J Neurochem; 1987 Aug; 49(2):617-21. PubMed ID: 3598589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
    Madras BK; Reith ME; Meltzer PC; Dutta AK
    Eur J Pharmacol; 1994 Apr; 267(2):167-73. PubMed ID: 8050478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionic requirements of [3H]GBR-12935 binding to the dopamine transporter in canine striatal membranes.
    Milner HE; Jarvis SM
    Biochem Soc Trans; 1992 Aug; 20(3):243S. PubMed ID: 1426538
    [No Abstract]   [Full Text] [Related]  

  • 35. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine.
    Debler EA; Hashim A; Lajtha A; Sershen H
    Life Sci; 1988; 42(25):2553-9. PubMed ID: 3260319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.
    Heikkila RE; Manzino L
    Eur J Pharmacol; 1984 Aug; 103(3-4):241-8. PubMed ID: 6237922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
    Bonnet JJ; Costentin J
    Eur J Pharmacol; 1986 Feb; 121(2):199-209. PubMed ID: 3754516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]GBR 12935 binding to dopamine uptake sites in the human brain.
    De Keyser J; De Backer JP; Ebinger G; Vauquelin G
    J Neurochem; 1989 Nov; 53(5):1400-4. PubMed ID: 2795007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.